Deletions or loss-of-function mutations in CBL are found in a wide range of myeloid malignancies, in particular, myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) overlap syndromes (6, 7). This evidence concerns the gene CBL and myeloproliferative disorder.